ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672073 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672073; 2) Community: the network communities that were significantly associated with the response to NSC 672073; 3) Molecule: the relationships between components within communities and NSC 672073; 4) MDR: the compounds that were significantly associated with the NSC 672073.

NSC Compound Enrichment Correlation
NSC 730478 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-5-androsten-3.beta.,17.beta.-diol 0.0454469012959173 -0.079754571
NSC 735037 Camptothecin Derivative 0.0454469012959173 0.054924602
NSC 736104 Null 0.0454469012959173 -0.066855864
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0454469012959173 0.14197803
NSC 754118 6-chloro-7-phenyl-8-(3,5-dimethoxybenzyl)- 5,8-dihydro-4H-isoxazolo[4,5-g]indole 0.0454469012959173 0.22328758
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0454469012959173 0.27951032
NSC 626676 Null 1.12445458734373e-005 0.19920788
NSC 244714 Benzoic acid, 3,5-dinitro-2-(1H-purin-6-ylthio)-, ethyl ester 1.80303315873685e-005 0.22897783
NSC 621322 Null 1.80303315873685e-005 0.093988618
NSC 666586 Null 1.80303315873685e-005 0.34387078
Total:88  Current:87    [First] [Prev] [Next] [Last]